Polar Capital Holdings Plc 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 0 0.000% |
-6,295,713 (Position Closed) |
Filing |
| 2022-02-14 10:47 am Purchase |
2021-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 6,295,713 6.400% |
495,713 (+8.55%) |
Filing |
| 2021-02-16 07:32 am Purchase |
2020-12-31 | 13G | Summit Therapeutics Inc. SMMT |
Polar Capital Holdings Plc | 5,800,000 7.050% |
5,800,000 (New Position) |
Filing |